Skip to main content

Specialty Menu Navigation

  • COVID-19

  • Clinical

  • Coronary

  • Structural

  • Endovascular

  • Heart Failure

  • Heart Rhythm

  • Imaging & Physiology

  • Policy & Practice

Top User Menu

  • CME
  • Register
  • Login
Advertisement

Main navigation

  • News
    • Conference News
    • Features
    • Opinion
  • Conferences
  • Slides
  • Specialties
    • COVID-19
    • Clinical
    • Coronary
    • Structural
    • Endovascular
    • Heart Failure
    • Heart Rhythm
    • Imaging & Physiology
    • Policy & Practice
  • Podcasts
    • Heart Sounds
    • Rox Heart Radio
    • TCTMD Talking Points
    • Taking It To Heart
    • Heart Valve Matters
  • Videos
    • All Videos
    • Interviews
    • Topical Discussions
    • On Record
    • Live Cases
    • Partner Content
  • Fellows Forum
  • CV Team Forum
  • News (40)
  • Partner Content (11)
  • CME (4)
  • Slides (2)
  • evergreen_page (1)
Podcast
  • Daily News
  • Conference News
  • Industry News
  • Features
  • Editor's Corner
  • Fellow Talk
  • TCT (3)
  • ACC (1)
  • Policy & Practice (15)
  • Guidelines (14)
  • Coronary (8)
  • Structural Heart (6)
  • ACS/AMI (5)
  • CAD Pharma (5)
  • Angiography/QCA (4)
  • Aortic Valve (4)
  • PFO/ASD (2)
  • Stroke (2)
  • Clinical Pharma (1)
  • DES/BRS/DCB (1)
  • Prevention (1)
  • Women's Heart (1)
  • (-) 2016 (58)
Displaying 41 - 58 of 58
Sort: Relevancy | Date
News Daily News

LANCELOT: Antiplatelet Agent Shows Positive Signs in Patients With ACS, Stable CAD

Jason Kahn
Jason Kahn
April 21, 2011
News Industry News

Boston Scientific Announces its ACC 2011 Schedule

March 29, 2011
The Latest Data on Expanded Indications and What it Means for Referring Cardiologists
CME

The Latest Data on Expanded Indications and What it Means for Referring Cardiologists

Partner Content

The Latest Data on Expanded Indications and What it Means for Referring Cardiologists

November 16, 2016

TCTMD Rate Card


 

Banner
Advertising
 
 
Email Newsletter
Advertising
 
 
Mobile
Advertising
 
 
Sponsored
Email Campaigns
 
Educational
Opportunities
 
TCTMD Audience /
Demographics
 
     
New Home Screen Shot   
Banner Advertising 

Ad Position #1
Location: Homepage
Dimensions: 409x60 IMU
Name: Rectangle
File Type(s) Allowed: JPEG, GIF, PNG  (no animation)
Maximum File Size: 50kB
Cost: $10,000


Ad Position #2
Location: Homepage

Dimensions: 270 x 225 IMU
Name: Rectangle
File Type(s) Allowed: JPEG, GIF, PNG (no animation)
Maximum File Size: 50kB
Cost: $10,000


Ad Position #3
Location: Homepage

Dimensions: 270 x 225 IMU
Name: Rectangle
File Type(s) Allowed: JPEG, GIF, PNG (no animation)
Maximum File Size: 50kB
Cost: $7,500


Ad Position #4
Location: Homepage
Dimensions: 270 x 225 IMU
Name: Custom
File Type(s) Allowed: JPEG, GIF, PNG 
(no animation)
Maximum File Size: 50kB
Cost: $7,500



Homepage Events Calendar
Location: Homepage
Dimensions: 
120 x 90 IMU
Name: Button 1
File Type(s) Allowed: 
JPEG, GIF, PNG (no animation)
Maximum File Size:25kB
Cost: $5,000



Events Package
Includes Event Calendar icon on the homepage (1 month) and Event Calendar icon in the TCTMD eletter (4 issues)

Location: Homepage & E-newsletter
Dimensions: 120 x 90 IMU
Name: Button 1
File Type(s) Allowed: JPEG, GIF, PNG (no animation)
Maximum File Size: 10kb
Cost:$7,500


Ad Position #5
Location: Content Pages
Dimensions: 
160 x 600 IMU
Name: Skyscraper
File Type(s) Allowed: JPEG, GIF, PNG
Maximum File Size: 50kb
Cost: $12,000



Skyscraper Package
Includes Ad Position #5 (one month)
and eletter Ad Position #1 (4 issues)


See above for banner ad specifications.


Cost:$30,000

Pricing is per month unless otherwise noted.

Back to top 
Multimedia Center Advertising 


MM 970x90 
 
Multimedia Center Advertising 


Multimedia Center / Virtual Sponsorship
Location: Multimedia Center
Dimensions: 300x250, 160x600, 970x90 IMU

Name: Rectangle and Skyscraper
File Type(s) Allowed: JPEG, GIF, PNG  (no animation)
Maximum File Size: 50kB

This sponsorship gives the supporting organization exclusive advertising throughout the Multimedia Center and runs for a period of 4 months coinciding with Virtual TCT, CTO/LM, and TVT, which are now hosted within the Multimedia Center.

Pricing:
(Jan. - Apr.): $40,000
(May - Aug.): $40,000
(Sep. - Dec.): $50,000


Pricing is for a 4 month placement.

Back to top 

  

 
    
Newsletter V2 

Events Calendar V2 
 
Newsletter Advertising 
Ad Position #1
Location: In-line with content
Dimensions: 640x100 IMU
Name: Rectangle
File Type(s) Allowed: JPEG, GIF, PNG
Maximum File Size: 25kb
Cost: $5,000


Event Banners
Location: In-line with content
Dimensions: 120x90 IMU
Name: Button 1 
File Type(s) Allowed: JPEG, GIF, PNG
Maximum File Size:10kb
Cost: $2,500


Insertion #1 (Lead Content)
Title: 20 words maximum
Body: 70 words maximum
Image Dimensions: 120 x 90 IMU
File Type(s) Allowed: JPEG or GIF
Name: Button 1
Maximum File Size:10kb
Cost: $7,500

Insertion #2 (Mid-Content)
Title: 20 words maximum
Body: 70 words maximum
Image Dimensions: 120 x 90 IMU
File Type(s) Allowed: JPEG or GIF
Name: Button 1
Maximum File Size: 10kb
Cost: $5,000

Pricing is per issue unless otherwise noted.  Newsletter is distributed each Monday (except on US holidays).

Back to top 

  

 

 
   
Mobile Ad Screenshots V3   
Mobile Advertising 
TCTMD App Footer
Location: TCTMD App (iOS and Andriod)
Dimensions: 640x96, 768x64, 1024x64 IMU 
Name: App Footer 
File Type(s) Allowed: JPEG, GIF, PNG  (no animation)
Maximum File Size: 25kB 
Notes: Rotates with up to 2 ads
Cost: $5,000

TCTMD App Splash Page
Location: TCTMD App (iOS and Andriod)
Dimensions:  640x960, 768x1004, 640x1136, 1024x748, 800x1280, 1280x800 IMU
Name: App Splash Page 
File Type(s) Allowed: JPEG, GIF, PNG  (no animation)
Maximum File Size: 50kB
Standard Cost: $10,000
Premium Cost*: $15,000

* Premium rates apply Sept. - Nov. 2015

Pricing is per month unless otherwise noted.

Back to top 
       

 
 Sponsored Eblast Ad 

 
 
Sponsored Email Messages 
 
Premium (Peak) 

$18,000 

Standard (Off-peak) 

$12,500 


Detailed delivery / open / clickthrough rate report provided.  Client may distribute to our master list or to our US or OUS lists.  Customized segmented lists are also available.

Client is responsible for the development and hosting of all assets.

CRF can now design & produce HTML eblasts as well as HTML and/or Flash-based landing sites on client's behalf.  Contact us for more information.

CRF can provide hosting of eblast assets.Contact us for more information.

[Download our 2016 Eblast Calendar]  

Pricing is based on a one time distribution to opt-in TCTMD members.

Back to top 

  
Educational Opportunites on TCTMD 

Community Sponsorship 
The goal of a therapeutic-focused community is to simplify the gathering of information on a particular therapeutic topic by aggregating all content in one section of the Web site where subscribers interested in that area can network, while offering COE sponsors corporate and product branding opportunities. Community support is accompanied by a major marketing campaign to increase awareness and interest in the area among our subscribers. Your company name appears with a link to the Community on the TCTMD homepage. Available Centers of Excellence include:
  • Coronary  
  • Chronic Total Occlusions 
  • Drug-eluting Stents  
  • Endovascular 
  • Imaging  
  • Pharmacology  
  • Structural 
 Other topics will be considered.
 
  
Educational Webcasts 

If you have an idea for a live or archived event that would be of interest to our community, we want to hear from you! We can handle all aspects of your event, including presenter participation, promotion, webcasting, and archiving the event on TCTMD.

 
CME Programs 

We have partnered with several leading CME providers to offer programs of interest to members of our community. The Cardiovascular Research Foundation (CRF) and TCTMD have extensive experience and capabilities in all facets of CME programs including live and enduring program management, production, recording, hosting, and promotion of the programs.

 
TCTMD Audience and Demographics 
  
  • 60,387 healthcare professionals are registered members 
  • 25,990 registered members are based in the US (48%) 
  • 34,397 registered members are based outside the US (52%) 
  • 41,680 registered members classify themselves as clinicians 
  • 35,992 registered members classify themselves as practicing cardiology 
  • 27,136 registered members classify themselves as practicing interventional cardiology 
  •  43,127 registered members are subscribed to our email list 
 
Information as of 10/01/2015 12:53 EDT 
 

 
Questions? Please Contact Us 

Should you have any questions about TCTMD advertising and sponsorships please email Steven Stavrou at sstavrou@crf.org.You can also contact us via our web form. Please remember to select "Sponsorships" when you submit the form. 
  

Back to top  

TAVR-Moving to Low Risk: New Devices/Strategies to Reduce Complications
CME

TAVR-Moving to Low Risk: New Devices/Strategies to Reduce Complications

Partner Content

TAVR-Moving to Low Risk: New Devices/Strategies to Reduce Complications

November 16, 2016
Partner Content

Registration: The Latest Data on Expanded Indications and What it Means for Referring Cardiologists

November 16, 2016
Partner Content

Registration: TAVR-Moving to Low Risk: New Devices/Strategies to Reduce Complications

November 21, 2016
Partner Content

Registration: Key Design Criteria for True Next Generation DES

November 21, 2016
Partner Content

Registration: A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

November 21, 2016
Key Design Criteria For True Next Generation DES
CME

Key Design Criteria For True Next Generation DES

Partner Content

Key Design Criteria for True Next Generation DES

November 16, 2016
Partner Content

Emerging Techniques in Mitral Valve Surgery

November 14, 2016
Partner Content

CME Landing Page

November 22, 2016
Partner Content

CME Credit: The Latest Data on Expanded Indications and What it Means for Referring Cardiologists

November 17, 2016
A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI
CME

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Partner Content

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

November 16, 2016

Pagination

  • First page « First
  • Previous page ‹‹
  • Page 1
  • Page 2
  • Current page 3
Advertisement
Become a Member

Register for TCTMD ®

Membership Plans
Sign Up for Our Newsletter

Receive the the latest news, research, and presentations from major meetings right to your inbox.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives. For more information, visit http://www.crf.org.

Main Navigation

  • News
  • Conferences
  • Slides
  • Videos
  • Podcasts
  • Fellows Forum
  • CV Team Forum
  • CME

Specialty Menu Navigation

  • COVID-19

  • Clinical

  • Coronary

  • Structural

  • Endovascular

  • Heart Failure

  • Heart Rhythm

  • Imaging & Physiology

  • Policy & Practice

Footer

  • Advertising & Sponsorships
  • About TCTMD ®
  • FAQs
  • Editorial Policy
  • Contact Us
  • About CRF ®
Digital Health Awards Winner - Spring 2017 eHealthcare Leadership Awards - 2018 Winner HON Code Certified
Copyright © 2025. TCTMD ® All rights reserved.
  • Privacy Policy
  • Terms of Use
Created by Constructive
Sign In

New at TCTMD? Register today!

Forgot Password

Forgot Your Password?

Enter the email you used to register to reset your password.

Search TCTMD
cme
CME TITLE
Sign up for our newsletter

Sign up to receive the most important cardiovascular news, research, and major meeting presentations.

Address
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Main navigation

  • News
    • Conference News
    • Features
    • Opinion
  • Conferences
  • Slides
  • Specialties
    • COVID-19
    • Clinical
    • Coronary
    • Structural
    • Endovascular
    • Heart Failure
    • Heart Rhythm
    • Imaging & Physiology
    • Policy & Practice
  • Podcasts
    • Heart Sounds
    • Rox Heart Radio
    • TCTMD Talking Points
    • Taking It To Heart
    • Heart Valve Matters
  • Videos
    • All Videos
    • Interviews
    • Topical Discussions
    • On Record
    • Live Cases
    • Partner Content
  • Fellows Forum
  • CV Team Forum

Top User Menu

  • CME
  • Register
  • Login

Search TCTMD

Submit an Event
< >

Become a PREMIUM MEMBER or LOG IN to view exclusive content

This content is available for meeting attendees and/or Platinum Members

REGISTER for free or LOG IN to view this content

Now Playing